These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21958537)

  • 21. Evaluation of drug release from gels on pig nasal mucosa in a horizontal Ussing chamber.
    Osth K; Paulsson M; Björk E; Edsman K
    J Control Release; 2002 Oct; 83(3):377-88. PubMed ID: 12387946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactants.
    Paulsson M; Edsman K
    Pharm Res; 2001 Nov; 18(11):1586-92. PubMed ID: 11758767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visualization and quantification of skin barrier perturbation induced by surfactant-humectant systems using two-photon fluorescence microscopy.
    Ghosh S; Kim D; So P; Blankschtein D
    J Cosmet Sci; 2008; 59(4):263-89. PubMed ID: 18818848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
    Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
    Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms behind the faceting of catanionic vesicles by polycations: chain crystallization and segregation.
    Antunes FE; Brito RO; Marques EF; Lindman B; Miguel M
    J Phys Chem B; 2007 Jan; 111(1):116-23. PubMed ID: 17201435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine.
    Baboota S; Shakeel F; Kohli K
    Methods Find Exp Clin Pharmacol; 2006 Mar; 28(2):109-14. PubMed ID: 16636721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol.
    Lim PF; Liu XY; Kang L; Ho PC; Chan YW; Chan SY
    Int J Pharm; 2006 Mar; 311(1-2):157-64. PubMed ID: 16451823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled drug release from gels using lipophilic interactions of charged substances with surfactants and polymers.
    Paulsson M; Edsman K
    J Colloid Interface Sci; 2002 Apr; 248(1):194-200. PubMed ID: 16290522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA encapsulation by biocompatible catanionic vesicles.
    Rosa M; Miguel Mda G; Lindman B
    J Colloid Interface Sci; 2007 Aug; 312(1):87-97. PubMed ID: 17547929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sorbitan ester niosomes for topical delivery of rofecoxib.
    Das MK; Palei NN
    Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design.
    Chopra S; Motwani SK; Iqbal Z; Talegaonkar S; Ahmad FJ; Khar RK
    Eur J Pharm Biopharm; 2007 Aug; 67(1):120-31. PubMed ID: 17270408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility.
    Efentakis M; Pagoni I; Vlachou M; Avgoustakis K
    Int J Pharm; 2007 Jul; 339(1-2):66-75. PubMed ID: 17408891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin.
    Yener G; Gönüllü U; Uner M; Değim T; Araman A
    Pharmazie; 2003 May; 58(5):330-3. PubMed ID: 12779049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
    Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
    J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of true nanoemulsions for transdermal potential of indomethacin: characterization, rheological characteristics, and ex vivo skin permeation studies.
    Shakeel F; Ramadan W; Ahmed MA
    J Drug Target; 2009 Jul; 17(6):435-41. PubMed ID: 19527114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photo-assisted gene delivery using light-responsive catanionic vesicles.
    Liu YC; Le Ny AL; Schmidt J; Talmon Y; Chmelka BF; Lee CT
    Langmuir; 2009 May; 25(10):5713-24. PubMed ID: 19435291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of additives on release and in vitro skin retention of flavonoids from emulsion and gel semisolid formulations.
    Dyja R; Jankowski A
    Int J Cosmet Sci; 2017 Aug; 39(4):442-449. PubMed ID: 28267214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gelation of charged catanionic vesicles prepared by a semispontaneous process.
    Huang ZL; Hong JY; Chang CH; Yang YM
    Langmuir; 2010 Feb; 26(4):2374-82. PubMed ID: 19928951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative permeation/release study of different testosterone gel formulations.
    Pabla D; Zia H
    Drug Deliv; 2007 Aug; 14(6):389-96. PubMed ID: 17701528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.